Invesco India Pharma and Healthcare Fund Direct Growth
Get the latest NAV of Invesco India Pharma and Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.
₹10.00
NAV as on 19 Aug 2026
Peer comparison
Invesco India Pharma and Healthcare Fund Overview
| NAV Price | ₹ 10 |
| Launch Date | 18 August 2026 |
| End Date | 01 September 2026 |
| Allotment Date | 08 September 2026 |
Exit Load | 0.5% |
Benchmark | BSE Healthcare TR INR |
| Min Lumpsum/SIP | ₹1,000/₹100 |
| Risk | Very High Risk |
About Invesco India Pharma and Healthcare Fund
Invesco India Pharma and Healthcare Fund is an equity new fund offer (NFO) launched by Invesco Asset Management (India) Private Ltd. The investors can apply to the NFO from 18 August 2026 to 01 September 2026. As per the SEBI defined riskometer, the Invesco India Pharma and Healthcare Fund is rated Very High Risk. Invesco India Pharma and Healthcare Fund has defined its benchmark as BSE Healthcare TR INR.
Fund Manager
Aditya Khemani
Fund Manager of Invesco India Pharma and Healthcare Fund, since 8 September 2026